Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.
Self-monitoring blood glucose (SMBG) devices is widely sold in public hospital, private hospital, clinics and pharmacy shops. The most proportion of self-monitoring blood glucose (SMBG) devices is sold in pharmacy shops, and the proportion in 2017is about 50.02%.
Central Thailand is the largest sales place, with a sales market share nearly 45.92% in 2017. Following Central Thailand, Northern Thailand is the second largest sales place with the market share of 24.97%.
The report offers detailed coverage of Self-Monitoring Blood Glucose (SMBG) Devices industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Self-Monitoring Blood Glucose (SMBG) Devices by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Self-Monitoring Blood Glucose (SMBG) Devices market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Self-Monitoring Blood Glucose (SMBG) Devices market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Roche
Lifescan
Abbott
Terumo
Ascensia (Bayer)
At the same time, we classify Self-Monitoring Blood Glucose (SMBG) Devices according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Strips
Glucose Meter
Lancet
Market by Application
Public Hospital
Private Hospital
Clinics
Pharmacy Shops
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Self-Monitoring Blood Glucose (SMBG) Devices market for the forecast period 2021 - 2025?
• What are the driving forces in the Self-Monitoring Blood Glucose (SMBG) Devices market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Self-Monitoring Blood Glucose (SMBG) Devices industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?